Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancerP Lissoni, F Rovelli, G Tancini, et al.
Recenti Progressi in Medicina|December 1, 1996
The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopeniaP Lissoni, G Tancini, S Barni, et al.
Anticancer Research|April 12, 2003
Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergolineP Lissoni, M Vaghi, S Villa, et al.
Giornale Italiano Di Cardiologia|July 1, 1990
[The cardiovascular toxicity of interleukin-2: the pathogenic mechanisms and treatment]P Lissoni, M A Galli, S Barni, et al.
Oncology|March 1, 1995
Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumorsP Lissoni, S Barni, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1994
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatoninR Brackowski, B Zubelewicz, W Romanowski, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
Stimulation of IL-12 secretion by GM-CSF in advanced cancer patientsP Lissoni, E Fumagalli, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2P Lissoni, M Cazzaniga, S Barni, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Relationship between estrogen receptors and CMF adjuvant chemotherapyG Bonadonna, G Di Fronzo, G Tancini, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancerP Lissoni, F Rovelli, G Tancini, et al.
Recenti Progressi in Medicina|December 1, 1996
The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopeniaP Lissoni, G Tancini, S Barni, et al.
Anticancer Research|April 12, 2003
Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergolineP Lissoni, M Vaghi, S Villa, et al.
Giornale Italiano Di Cardiologia|July 1, 1990
[The cardiovascular toxicity of interleukin-2: the pathogenic mechanisms and treatment]P Lissoni, M A Galli, S Barni, et al.
Oncology|March 1, 1995
Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumorsP Lissoni, S Barni, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1994
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatoninR Brackowski, B Zubelewicz, W Romanowski, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
Stimulation of IL-12 secretion by GM-CSF in advanced cancer patientsP Lissoni, E Fumagalli, F Malugani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2P Lissoni, M Cazzaniga, S Barni, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Relationship between estrogen receptors and CMF adjuvant chemotherapyG Bonadonna, G Di Fronzo, G Tancini, et al.
Pageof 22